AAAAI 2021

Patients with asthma who depend on oral corticosteroids (OCS) may be able to reduce the dependence or eliminate the use of OCS altogether with benralizumab.

Mepolizumab reduces disease symptoms in patients with chronic rhinosinusitis with nasal polyps, according to the results of a randomized, double-blind, multicenter study.

Berotralstat may reduce the use of on-demand medications in patients with hereditary angioedema (HAE) who were previously treated with prophylactic therapies.

In patients with moderate to severe chronic rhinosinusitis with nasal polyposis, treatment with an Exhalation Delivery System With Fluticasone (EDS-FLU) is associated with improved sleep scores.

Researchers studied subgroups of patients with uncontrolled asthma to determine if cardiovascular risk would affect their response to umeclidinium added to fluticasone furoate/vilanterol.

Black/African American and Hispanic individuals compared with White/Caucasian individuals were found to be highly underrepresented in food allergy immunotherapy trials.

The use of CREON2000A UV air irradiation system technology reduced asthma severity in children with mild to moderate asthma.

Treatment with trimethoprim-sulfamethoxazole was associated with improvements in lung function and decreased visits to the emergency department among children with asthma.

Budesonide oral suspension improved histologic, endoscopic, and both histologic and symptomatic outcomes in children with eosinophilic esophagitis compared with placebo.

A single dose of PHA-022121, an oral beta-2 antagonist, was associated with effective bradykinin-inhibiting concentrations within 15 minutes of administration in patients with hereditary angioedema.